New hope for tough lymphoma: drug combo trial launches
Disease control
Not yet recruiting
This study tests a combination of two drugs, mitoxantrone hydrochloride liposome and enlonstobart, in people with a type of blood cancer called peripheral T-cell lymphoma that has come back or not responded to treatment. The goal is to find the best dose and see if the combinatio…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-Sen University Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:55 UTC